534
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Medication Adherence and Its Associated Factors Among Outpatients with Heart Failure

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1209-1220 | Received 28 Feb 2023, Accepted 28 Apr 2023, Published online: 08 May 2023

References

  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of. Eur Heart J. 2016;37(27):2129–2200m. doi:10.1093/EURHEARTJ/EHW128
  • James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
  • Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619. doi:10.1161/HHF.0B013E318291329A
  • Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206. doi:10.1016/J.EJCNURSE.2005.03.010
  • World Health Organization. Noncommunicable diseases country profiles 2018. World Health Organization; 2018:223. Available from: http://www.who.int/iris/handle/10665/274512. Accessed August 15, 2022.
  • Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med. 2007;167(5):490–496. doi:10.1001/ARCHINTE.167.5.490
  • Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–779. doi:10.1016/J.AHJ.2007.12.011
  • Zahwe M, Isma’eel H, Skouri H, et al. Validation of the Arabic version of the Minnesota living with heart failure questionnaire. Hear Lung. 2020;49(1):36–41. doi:10.1016/j.hrtlng.2019.10.006
  • World Health Organization. Adherence to long-term therapies: evidence for action / [‎edited by Eduardo Sabaté]‎; 2003. Available from: https://apps.who.int/iris/handle/10665/42682. Accessed January 6, 2022.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinic. Circulation. 2016;134(13):e282–e293. doi:10.1161/CIR.0000000000000435/-/DC1
  • Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007;21(4):311–316. doi:10.1007/S10557-007-6040-4
  • Calvin JE, Shanbhag S, Avery E, Kane J, Richardson D, Powell L. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART). Congest Hear Fail. 2012;18(2):73–78. doi:10.1111/J.1751-7133.2011.00263.X
  • Nieuwenhuis MMW, Jaarsma T, van Veldhuisen DJ, van der Wal MHL. Self-reported versus ‘true’ adherence in heart failure patients: a study using the medication event monitoring system. Netherlands Hear J. 2012;20(7):313–319. doi:10.1007/S12471-012-0283-9
  • Viana M, Laszczynska O, Mendes S, et al. Medication adherence to specific drug classes in chronic heart failure. J Manag Care Spec Pharm. 2015;20(10):1018–1026. doi:10.18553/JMCP.2014.20.10.1018
  • Fitzgerald AA, Powers JD, Ho PM, et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011;17(8):664–669. doi:10.1016/J.CARDFAIL.2011.04.011
  • Aggarwal B, Pender A, Mosca L, Mochari-Greenberger H. Factors associated with medication adherence among heart failure patients and their caregivers. J Nurs Educ Pract. 2014;5(3):22. doi:10.5430/JNEP.V5N3P22
  • Shaheen H, Haq N, Riaz S, Naseem A, Zarak M. Assessment of medication adherence among non-communicable chronic disease patients in Quetta, Pakistan: predictors of medication adherence. Asian J Med Heal. 2017;4(4):1–9. doi:10.9734/AJMAH/2017/34300
  • Toh CT, Jackson B, Gascard DJ, Manning AR, Tuck EJ. Barriers to medication adherence in chronic heart failure patients during home visits. J Pharm Pract Res. 2010;40(1):27–30. doi:10.1002/J.2055-2335.2010.TB00721.X
  • Elhenawy YI, Abdelmageed RI, Zaafar DK, Abdelaziz AW. Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic version of the 4-item morisky medication adherence scale. Patient Prefer Adherence. 2022;16:1415–1421. doi:10.2147/PPA.S341061
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res. 1991;26(3):499–510. doi:10.1207/S15327906MBR2603_7
  • Awad A, Osman N, Altayib S. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study. Cardiovasc J Afr. 2017;28(6):350–355. doi:10.5830/CVJA-2017-016
  • Di Martino M, Alagna M, Cappai G, et al. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design. BMJ Open. 2016;6(4):e010926. doi:10.1136/BMJOPEN-2015-010926
  • Ezeala-Adikaibe B, Mbadiwe N, Okudo G, Nwosu N, Nwobodo N. Factors associated with medication adherence among hypertensive patients in a tertiary health center: a cross-sectional study. Arch Community Med Public Heal. 2017;3(1):024–031. doi:10.17352/2455-5479.000021
  • Mosleh SM, Almalik MMA. Illness perception and adherence to healthy behaviour in Jordanian coronary heart disease patients. Eur J Cardiovasc Nurs. 2016;15(4):223–230. doi:10.1177/1474515114563885
  • Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2013;36(11):1000–1005. doi:10.1038/hr.2013.85
  • Monane M, Bohn R, Gurwitz J, Glynn R, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154(4):433–437. doi:10.1001/archinte.1994.00420040107014
  • Pallangyo P, Millinga J, Bhalia S, et al. Medication adherence and survival among hospitalized heart failure patients in a tertiary hospital in Tanzania: a prospective cohort study. BMC Res Notes. 2020;13(1):1–8. doi:10.1186/S13104-020-04959-W/FIGURES/1
  • Silavanich V, Nathisuwan S, Phrommintikul A, Permsuwan U. Relationship of medication adherence and quality of life among heart failure patients. Hear Lung. 2019;48(2):105–110. doi:10.1016/j.hrtlng.2018.09.009
  • Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Hear Lung J Acute Crit Care. 2001;30(4):294–301. doi:10.1067/mhl.2001.116011
  • Artinian NT, Magnan M, Sloan M, Lange MP. Self-care behaviors among patients with heart failure. Hear Lung J Acute Crit Care. 2002;31(3):161–172. doi:10.1067/mhl.2002.123672
  • Van Der Wal MHL, Jaarsma T, Van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail. 2005;7(1):5–17. doi:10.1016/J.EJHEART.2004.04.007
  • Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Heal Educ Behav. 2009;36(1):127–137. doi:10.1177/1090198107309459
  • Braverman J, Dedier J. Predictors of medication adherence for African American patients diagnosed with hypertension. Ethn Dis. 2009;19(4):396–400.
  • Basheti IA, Saqf El Hait S, Qunaibi EA, Aburuz S, Bulatova N. Associations between patient factors and medication adherence: a Jordanian experience. Pharm Pract. 2016;14(1). doi:10.18549/PHARMPRACT.2016.01.639
  • Snyder VL. Improving outcomes in heart failure: an interdisciplinary approach. AORN J. 2001;74(4):558–559. doi:10.1016/S0001-2092(06)61697-9
  • Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455–461. doi:10.1001/JAMA.288.4.455
  • Jackevicius CA, Mamdani M, Tu JV. adherence with Statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–467. doi:10.1001/JAMA.288.4.462
  • Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to Statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28(3):595–599. doi:10.2337/DIACARE.28.3.595
  • Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662–1666. doi:10.1016/j.amjcard.2011.01.052
  • Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 2001;87(3):257–261. doi:10.1016/S0002-9149(00)01354-0
  • Pedan A, Varasteh LT, Schneeweiss S. Analysis of factors associated with Statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm. 2015;13(6):487–496. doi:10.18553/JMCP.2007.13.6.487
  • Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23(2):1–87. doi:10.4158/EP171764.APPGL
  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi:10.1093/EURHEARTJ/EHT295
  • Simpson RJ, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol. 2010;4(6):462–471. doi:10.1016/j.jacl.2010.08.026
  • Tajeu GS, Kent ST, Huang L, et al. Antihypertensive medication nonpersistence and low adherence for adults. Hypertens. 2019;74(1):35–46. doi:10.1161/HYPERTENSIONAHA.118.12495
  • Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611. doi:10.1161/CIRCULATIONAHA.110.983874
  • Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007;20(1):72–80. doi:10.3122/JABFM.2007.01.060094
  • Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–1310. doi:10.1016/S0149-2918(01)80109-0
  • Kneeland PP, Fang MC. Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010;4:51–60. doi:10.2147/PPA.S6101
  • Park S, Jang I. Factors affecting medication adherence in patients with mechanical heart valves taking warfarin: the role of knowledge on warfarin, medication belief, depression, and self-efficacy. Int J Environ Res Public Heal. 2021;18(10):5214. doi:10.3390/IJERPH18105214
  • Eapen ZJ, Mi X, Qualls LG, et al. Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. J Card Fail. 2014;20(1):23–30. doi:10.1016/J.CARDFAIL.2013.11.006
  • Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European society of cardiology committee for practice. Circulation. 2006;114(7). doi:10.1161/CIRCULATIONAHA.106.177292
  • Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(1):104–123. doi:10.1161/CIR.0B013E3181FA3CF4
  • Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GYH. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123(7):638–645.e4. doi:10.1016/J.AMJMED.2009.11.025
  • Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SSK. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging. 2008;25(10):885–892. doi:10.2165/00002512-200825100-00008
  • Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171(9):814–822. doi:10.1001/ARCHINTERNMED.2010.495
  • Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35(5):539–545. doi:10.1345/APH.10295
  • Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf. 2009;18(8):672–681. doi:10.1002/PDS.1766
  • Stoehr GP, Lu SY, Lavery L, et al. Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey. Am J Geriatr Pharmacother. 2008;6(5):255–263. doi:10.1016/J.AMJOPHARM.2008.11.001
  • Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408–1412. doi:10.2337/DIACARE.26.5.1408
  • Ownby RL, Hertzog C, Crocco E, Duara R. Factors related to medication adherence in memory disorder clinic patients. Aging Ment Health. 2006;10(4):378–385. doi:10.1080/13607860500410011